Home > News > Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
August 4th, 2004
Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
Nanogen Inc., maker of the NanoChip molecular diagnostics system for biologic research, saw its stock drop nearly 21 percent today after posting a second-quarter loss that almost doubled its loss of a year ago. Nanogen shares (Nasdaq: NGEN) fell 99 cents, or 20.6 percent, to close at $3.81 today. The firm has a market cap of $97.65 million.
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 August 12th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Harris & Harris Group Reports Financial Statements as of June 30, 2014 August 10th, 2014